PROSTATE BIOPSY IN THE OUTPATIENT SETTING
- Authors: Rokhlikov I.M1, Samsonov A.V1, Onishchenko O.V1, Andreyev Y.Y.1, Makanin M.A1
-
Affiliations:
- Issue: No 6 (2012)
- Pages: 62-69
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/279642
- ID: 279642
Cite item
Open Access
Access granted
Abstract
The article describes the methodology of transrectal diagnostic prostate biopsy under ultrasound guidance with regard to settings of municipal polyclinic; existing complications are listed. The analysis of the results of 876 biopsies performed within 3 years is presented. The distribution of the results of histological examination depending on the level of total PSA, ratio of free and total PSA, and PSA density was followed-up. Relationship between PC detection rate using standard biopsy and prostate volume is shown. The analysis of the degree of PC differentiation (Gleason score) depending on the level of total PSA, the ratio of free and total PSA, and PSA density was performed. Practical recommendations to improvement of PC detection rate are presented. Based on the analysis, it was concluded that the screening for prostate cancer for the purpose of its earlier diagnosis is reasonable.
Full Text
About the authors
I. M Rokhlikov
Email: rohim@urol-androl.ru
A. V Samsonov
O. V Onishchenko
Yu. Yu Andreyev
M. A Makanin
References
- Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004. Ann. Oncol. 2005;16(3):481-488.
- Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
- Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int. 2002;90(2):162—173.
- Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000: the global picture. Eur. J. Cancer. 2001;37(Suppl. 8):4-66.
- Cancer incidence in Sweden 2004. The National Board of Health and Welfare: Stockholm. http://sjp.sagepub.com/cgi/reprint/34/67_ suppl/3.pdf
- EAU Guidelines on Prostate Cancer. A. Heidenreich (chairman), M. Bolla, S. Joniau, M.D. Mason, V. Matveev, N. Mottet, H-P. Schmid,T.H. van der Kwast, T. Wiegel, F. Zattoni, 2010 http:// www.europeanurology.com/article/S0302-2838(07)01145-1
- Remzi M., Fong Y.K., Dobrovits M. et. al. from Dept. Urology, U. of Vienna, Vienna, Austria, “The Vienna Nomogram: Validation of a Novel Biopsy Strategy Defining the Optimal Number of Cores Based on Patient Age and Total Prostate Volume”, J. Urology 174:1256-1261, October, 2005. http://www.theeffectivetruth.info/ prosviennanom.html
- Пушкарь Д.Ю. Простат-специфический антиген и биопсия предстательной железы. М., МЕДпресс-информ, 2003.
- Пушкарь Д.Ю., Говоров А.В. Биопсия предстательной железы. М., ГЭОТАР-Медиа, 2010.
Supplementary files
